Skip to content

RelayPro Thoracic Stent-Graft System 28-N4-38-199-34URecalls & reported problems

Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant

All models of RelayPro Thoracic Stent-Graft System (127)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
2

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00843576151086), received between May 1, 2024 and Jul 8, 2025 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Device Endoleak” (1 report).

2 FDA recall records name this device's identifier, 2 still open.

1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 1 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Recalls naming this device

  1. Apr 22, 2026Class IOpen, Classified

    Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.

    Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

  2. Dec 20, 2022Class IIOpen, Classified

    The product may be shorter than packaging indicates

    Z-0998-2023 · Root cause: Labeling Change Control · Recall details · FDA record ↗

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem1
  • Device Endoleak1
  • Device Slipped1
  • Failure to Seal1
  • Insufficient Device Problem Information1

Patient problems

  • Aneurysm expansion1
  • Clinical Endoleak1
  • Insufficient Information1
  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryJul 8, 2025Device Slipped; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Failure to Seal; Device Endoleak; Device Slipped; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Failure to Seal; Device Endoleak

    "TYPE IA ENDOLEAK DUE TO STENT-GRAFT MIGRATION: ON (B)(6) 2023, THE PATIENT HAD THE RELAY PRO STENT-GRAFT IMPLANTED. THIS MONTH, POSTOPERATIVE FOLLOW-UP CT SCAN REVEALED THAT THE STENT-GRAFT, WHICH HAD BEEN IMPLANTED FROM THE POSITION RIGHT BELOW THE LEFT COMMON CAROTID ARTERY, MIGRATED TO THE POSITION OF THE AORTIC ARCH AORTA ANEURYSM RIGHT BELOW THE LEFT SUBCLAVIAN ARTERY, WHICH CAUSED A TYPE IA ENDOLEAK AND ENLARGEMENT OF THE ANEURYSM. THE PHYSICIAN SUGGESTED AN ADDITIONAL PROCEDURE, BUT THE PATIENT AND FAMILY PREFERRED NOT TO HAVE THE PROCEDURE PERFORMED BECAUSE OF THE PATIENT'S ADVANCED AGE. THE PATIENT IS THEREFORE BEING FOLLOWED UP. OPERATION TYPE: TEVAR NO BLOOD LOSS. NO IMAGE AVAILABLE DUE TO HOSPITAL POLICY. NO PRE-CASE PLAN AVAILABLE DUE TO HOSPITAL POLICY. NO ADDITIONAL INFORMATION AVAILABLE DUE TO HOSPITAL POLICY. (TC#(B)(4). PATIENT OUTCOME: "HEALTH DAMAGE TO THE PATIENT IS UNKNOWN. DUE TO THE PATIENT'S ADVANCED AGE, NO ADDITIONAL PROCEDURE WAS PERFORMED ACCORDING TO THE WISHES OF THE PATIENT AND FAMILY, AND THE PATIENT IS BEING FOLLOWED UP."

    Patient problems: Aneurysm expansion; Clinical Endoleak; Insufficient Information

    MAUDE report 22440620 ↗
  • MalfunctionMay 1, 2024

    A TERUMO AORTIC RELAY PRO 38/34 X 199 MM DEVICE WAS ADVANCED OVER THE LUNDERQUIST WIRE FROM THE LEFT FEMORAL ACCESS. THERE WAS SOME DIFFICULTY ENTERING THE DISTAL ASPECT OF THE PROXIMAL DEVICE WITH THE DELIVERY SYSTEM BUT WITH REPOSITIONING OF THE STIFF WIRE, THE DEVICE WAS ABLE TO ADVANCE WITHOUT DIFFICULTY TO THE PROPER LEVEL OF OVERLAP WITH THE PROXIMAL DEVICE. THE DEVICE WAS THEN SUCCESSFULLY DEPLOYED UNDER FLUOROSCOPIC GUIDANCE WITH THE DISTAL ASPECT TERMINATING JUST ABOVE THE LEVEL OF THE CELIAC ARTERY. THE PROXIMAL CLASPS WERE RELEASED AND THE NOSE CONE WAS ATTEMPTED TO BRING THROUGH THE DISTAL DEVICE; HOWEVER, THE NOSE CONE INADVERTENTLY CAUGHT THE PROXIMAL STENT APEX OF THE SECOND DEVICE AND PULLED THE PROXIMAL PORTION OF THE DEVICE WHICH WAS OVERLAPPED WITH THE INITIAL DEVICE APPROXIMATELY 6-8 CM DOWN, INVOLUTING IT WITHIN THE REMAINDER OF THE DEVICE. THIS WAS OBSERVED UNDER FLUOROSCOPIC GUIDANCE AND REMOVAL OF THE DELIVERY SYSTEM WAS ABORTED. THE DELIVERY SYSTEM WAS THEN CAREFULLY READVANCED WHICH SUCCESSFULLY REPOSITIONED THE PROXIMAL PORTION OF THE SECOND DEVICE MUCH MORE PROXIMALLY BUT NOT AS PROXIMAL AS NEEDED FOR ACCEPTABLE OVERLAP. ADDITIONALLY, THE DEVICE APPEARED

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 19220290 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.

  • Z-1383-2024 · Feb 22, 2024 · Completed
    RELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2

Other System, Endovascular Graft, Aortic Aneurysm Treatment devices

All System, Endovascular Graft, Aortic Aneurysm Treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page